Additional file 2: of An optimised method for the proteomic profiling of full thickness human skin

Table detailing the proteins identified in the final method (Fig. 2). (XLSX 120 kb

Additional file 1: of An optimised method for the proteomic profiling of full thickness human skin

Table detailing the proteins identifed in the original method (Fig. 1). (XLSX 19 kb

Additional file 1: Table S1. of Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease

Details of patients with other neurodegenerative diseases. (DOCX 13 kb

Additional file 2: Table S2. of Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease

Characteristics of AD patients and controls sampled in a replication cohort. Data expressed as mean ± SD or median (IQR) as appropriate. Probability values (p) denote differences between control and AD. A χ2 test was used for gender and APOE genotype comparisons. CSF biomarkers and sTREM2 were evaluated using the Mann-Whitney U test. (DOCX 14 kb

Additional file 6: of The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease

Table S6. Webgestalt GO ontology terms showing decreased expression in the presubiculum compared to the entorhinal cortex in Alzheimer’s disease post-mortem brain tissue. (DOCX 18 kb

Additional file 3: of The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease

Table S3. Proteins identified in supernatant with decreased expression in the presubiculum compared to the entorhinal cortex in Alzheimer’s disease post-mortem brain tissue. (DOCX 24 kb

Additional file 2: of The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease

Table S2. Proteins identified in the pellet with increased expression in the presubiculum compared to the entorhinal cortex in Alzheimer’s disease post-mortem brain tissue. (DOCX 38 kb